The role of BDNF in Alzheimer's disease

Neurobiology of Disease

Volumn 97, Issue , 2017, Pages 114-118

  Tanila, Heikki ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Amyloid plaque; Memory; Mouse; Neurotrophin; Synaptic plasticity; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR;

ALZHEIMER DISEASE; AMINO ACID BRAIN LEVEL; BDNF GENE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BRAIN; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS;

EID: 84969919986     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.05.008     Document Type: Review

References (77)

1. Adamczuk, K., De Weer, A.S., Nelissen, N., Chen, K., Sleegers, K., Bettens, K., Van Broeckhoven, C., Vandenbulcke, M., Thiyyagura, P., Dupont, P., Van Laere, K., Reiman, E.M., Vandenberghe, R., Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers. Neuroimage Clin. 2 (2013), 512–520.
2. Allen, S.J., Wilcock, G.K., Dawbarn, D., Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem. Biophys. Res. Commun. 264 (1999), 648–651.
3. Angelucci, F., Spalletta, G., di Iulio, F., Ciaramella, A., Salani, F., Colantoni, L., Varsi, A.E., Gianni, W., Sancesario, G., Caltagirone, C., Bossu, P., Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr. Alzheimer Res. 7 (2010), 15–20.
4. Arancibia, S., Silhol, M., Moulière, F., Meffre, J., Höllinger, I., Maurice, T., Tapia-Arancibia, L., Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 31 (2008), 316–326.
5. Bell, K.F., Ducatenzeiler, A., Ribeiro-da-Silva, A., Duff, K., Bennett, D.A., Cuello, A.C., The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol. Aging 27 (2006), 1644–1657.
6. Belrose, J.C., Masoudi, R., Michalski, B., Fahnestock, M., Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies. Neurobiol. Aging 35 (2014), 926–933.
7. Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N.A., Müller, F.J., Loring, J.F., Yamasaki, T.R., Poon, W.W., Green, K.N., LaFerla, F.M., Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 13594–13599.
8. Boado, R.J., Zhang, Y., Zhang, Y., Pardridge, W.M., Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier. Biotechnol. Bioeng. 97 (2007), 1376–1386.
9. Burbach, G.J., Hellweg, R., Haas, C.A., Del Turco, D., Deicke, U., Abramowski, D., Jucker, M., Staufenbiel, M., Deller, T., Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J. Neurosci. 24 (2004), 2421–2430.
10. Burnouf, S., Belarbi, K., Troquier, L., Derisbourg, M., Demeyer, D., Leboucher, A., Laurent, C., Hamdane, M., Buee, L., Blum, D., Hippocampal BDNF expression in a tau transgenic mouse model. Curr. Alzheimer Res. 9 (2012), 406–410.
11. Castello, N.A., Green, K.N., LaFerla, F.M., Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Abeta or tau pathology. PLoS One, 7, 2012, e39566.
12. Coelho, F.G., Vital, T.M., Stein, A.M., Arantes, F.J., Rueda, A.V., Camarini, R., Teodorov, E., Santos-Galduróz, R.F., Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease. J. Alzheimers Dis. 39 (2014), 401–408.
13. Connor, B., Young, D., Lawlor, P., Gai, W., Waldvogel, H., Faull, R.L., Dragunow, M., Trk receptor alterations in Alzheimer's disease. Brain Res. Mol. Brain Res. 42 (1996), 1–17.
14. Connor, B., Young, D., Yan, Q., Faull, R.L., Synek, B., Dragunow, M., Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 49 (1997), 71–81.
15. Cotman, C.W., Berchtold, N.C., Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 25 (2002), 295–301.
16. Criscuolo, C., Fabiani, C., Bonadonna, C., Origlia, N., Domenici, L., BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation. Neurobiol. Aging 36 (2015), 1303–1309.
17. DaRocha-Souto, B., Coma, M., Pérez-Nievas, B.G., Scotton, T.C., Siao, M., Sánchez-Ferrer, P., Hashimoto, T., Fan, Z., Hudry, E., Barroeta, I., Serenó, L., Rodríguez, M., Sánchez, M.B., Hyman, B.T., Gómez-Isla, T., Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease. Neurobiol. Dis. 45 (2012), 425–437.
18. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., Weinberger, D.R., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003), 257–269.
19. Eide, F.F., Vining, E.R., Eide, B.L., Zang, K., Wang, X.Y., Reichardt, L.F., Naturally occurring truncated TrkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 16 (1996), 3123–3129.
20. Elliott, E., Atlas, R., Lange, A., Ginzburg, I., Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 kinase signalling mechanism. Eur. J. Neurosci. 22 (2005), 1081–1089.
21. Erickson, K.I., Voss, M.W., Prakash, R.S., Basak, C., Szabo, A., Chaddock, L., Kim, J.S., Heo, S., Alves, H., White, S.M., Wojcicki, T.R., Mailey, E., Vieira, V.J., Martin, S.A., Pence, B.D., Woods, J.A., McAuley, E., Kramer, A.F., Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 3017–3022.
22. Fahnestock, M., Garzon, D., Holsinger, R.M., Michalski, B., Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?. J. Neural Transm. Suppl. 62 (2002), 241–252.
23. Fahnestock, M., Marchese, M., Head, E., Pop, V., Michalski, B., Milgram, W.N., Cotman, C.W., BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol. Aging 33 (2012), 546–554.
24. Ferrer, I., Marin, C., Rey, M.J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., Marti, E., BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58 (1999), 729–739.
25. Garzon, D.J., Fahnestock, M., Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J. Neurosci. 27 (2007), 2628–2635.
26. Garzon, D., Yu, G., Fahnestock, M., A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J. Neurochem. 82 (2002), 1058–1064.
27. Ginsberg, S.D., Che, S., Wuu, J., Counts, S.E., Mufson, E.J., Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J. Neurochem. 97 (2006), 475–487.
28. Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F., Weinberger, D.R., Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 (2003), 6690–6694.
29. Harris, S.E., Fox, H., Wright, A.F., Hayward, C., Starr, J.M., Whalley, L.J., Deary, I.J., The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol. Psychiatry 11 (2006), 505–513.
30. Hock, C., Heese, K., Hulette, C., Rosenberg, C., Otten, U., Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57 (2000), 846–851.
31. Holback, S., Adlerz, L., Iverfeldt, K., Increased processing of APLP2 and APP with concomitant formation of APP intracellular domains in BDNF and retinoic acid-differentiated human neuroblastoma cells. J. Neurochem. 95 (2005), 1059–1068.
32. Holsinger, R.M., Schnarr, J., Henry, P., Castelo, V.T., Fahnestock, M., Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res. Mol. Brain Res. 76 (2000), 347–354.
33. Honea, R.A., Cruchaga, C., Perea, R.D., Saykin, A.J., Burns, J.M., Weinberger, D.R., Goate, A.M., Alzheimer's Disease Neuroimaging Initiative (ADNI). Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration. PLoS One, 8, 2013, e76001.
34. Hsiao, Y.H., Hung, H.C., Chen, S.H., Gean, P.W., Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis. J. Neurosci. 34 (2014), 16207–16219.
35. Huang, E.J., Reichardt, L.F., Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 (2001), 677–736.
36. Jerónimo-Santos, A., Fonseca-Gomes, J., Guimarães, D.A., Tanqueiro, S.R., Ramalho, R.M., Ribeiro, J.A., Sebastião, A.M., Diógenes, M.J., Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation. Growth Factors 33 (2015), 298–308.
37. Kemppainen, S., Rantamäki, T., Jerónimo-Santos, A., Lavasseur, G., Autio, H., Karpova, N., Kärkkäinen, E., Stavén, S., Vicente Miranda, H., Outeiro, T.F., Diógenes, M.J., Laroche, S., Davis, S., Sebastião, A.M., Castrén, E., Tanila, H., Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol. Aging 33 (2012), 1122.e23–1122.e39.
38. Kitiyanant, N., Kitiyanant, Y., Svendsen, C.N., Thangnipon, W., BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons. Neurochem. Res. 37 (2012), 143–152.
39. Koponen, E., Voikar, V., Riekki, R., Saarelainen, T., Rauramaa, T., Rauvala, H., Taira, T., Castrén, E., Transgenic mice overexpressing the full-length neurotrophin receptor TrkB exhibit increased activation of the TrkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol. Cell. Neurosci. 26 (2004), 166–181.
40. Lim, Y., Zhong, J.H., Zhou, X.F., Development of mature BDNF-specific sandwich ELISA. J. Neurochem. 134 (2015), 75–85.
41. Lim, Y.Y., Villemagne, V.L., Laws, S.M., Ames, D., Pietrzak, R.H., Ellis, K.A., Harrington, K.D., Bourgeat, P., Salvado, O., Darby, D., Snyder, P.J., Bush, A.I., Martins, R.N., Masters, C.L., Rowe, C.C., Nathan, P.J., Maruff, P., Australian imaging, biomarkers and lifestyle (AIBL) research group. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiol. Aging 34 (2013), 2457–2464.
42. Massa, S.M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J.N., Nehama, D., Rajadas, J., Longo, F.M., Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J. Clin. Invest. 120 (2010), 1774–1785.
43. Mattson, M.P., Maudsley, S., Martin, B., BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 27 (2004), 589–594.
44. Michaelsen, K., Zagrebelsky, M., Berndt-Huch, J., Polack, M., Buschler, A., Sendtner, M., Korte, M., Neurotrophin receptors TrkB.T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons. Eur. J. Neurosci. 32 (2010), 1854–1865.
45. Minichiello, L., TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci. 10 (2009), 850–860.
46. Minichiello, L., Korte, M., Wolfer, D., Kuhn, R., Unsicker, K., Cestari, V., Rossi-Arnaud, C., Lipp, H.P., Bonhoeffer, T., Klein, R., Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24 (1999), 401–414.
47. Murer, M.G., Boissiere, F., Yan, Q., Hunot, S., Villares, J., Faucheux, B., Agid, Y., Hirsch, E., Raisman-Vozari, R., An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88 (1999), 1015–1032.
48. Nagahara, A.H., Mateling, M., Kovacs, I., Wang, L., Eggert, S., Rockenstein, E., Koo, E.H., Masliah, E., Tuszynski, M.H., Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J. Neurosci. 33 (2013), 15596–15602.
49. Nagahara, A.H., Merrill, D.A., Coppola, G., Tsukada, S., Schroeder, B.E., Shaked, G.M., Wang, L., Blesch, A., Kim, A., Conner, J.M., Rockenstein, E., Chao, M.V., Koo, E.H., Geschwind, D., Masliah, E., Chiba, A.A., Tuszynski, M.H., Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 15 (2009), 331–337.
50. Narisawa-Saito, M., Wakabayashi, K., Tsuji, S., Takahashi, H., Nawa, H., Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7 (1996), 2925–2928.
51. O'Bryant, S.E., Hobson, V.L., Hall, J.R., Barber, R.C., Zhang, S., Johnson, L., Diaz-Arrastia, R., Texas Alzheimer's research consortium. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement. Geriatr. Cogn. Disord. 31 (2011), 31–36.
52. O'Bryant, S.E., Hobson, V., Hall, J.R., Waring, S.C., Chan, W., Massman, P., Lacritz, L., Cullum, C.M., Diaz-Arrastia, R., Texas Alzheimer's research consortium. Brain-derived neurotrophic factor levels in Alzheimer's disease. J. Alzheimers Dis. 17 (2009), 337–341.
53. Peng, S., Wuu, J., Mufson, E.J., Fahnestock, M., Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J. Neurochem. 93 (2005), 1412–1421.
54. Peng, S., Garzon, D.J., Marchese, M., Klein, W., Ginsberg, S.D., Francis, B.M., Mount, H.T., Mufson, E.J., Salehi, A., Fahnestock, M., Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J. Neurosci 29 (2009), 9321–9329.
55. Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A., Winslow, J.W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7 (1991), 695–702.
56. Poo, M.M., Neurotrophins as synaptic modulators. Nat. Rev. Neurosci 2 (2001), 24–32.
57. Poon, W.W., Carlos, A.J., Aguilar, B.L., Berchtold, N.C., Kawano, C.K., Zograbyan, V., Yaopruke, T., Shelanski, M., Cotman, C.W., β-amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1. J. Biol. Chem. 288 (2013), 16937–16948.
58. Ramser, E.M., Gan, K.J., Decker, H., Fan, E.Y., Suzuki, M.M., Ferreira, S.T., Silverman, M.A., Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol. Biol. Cell 24 (2013), 2494–2505.
59. Rantamäki, T., Kemppainen, S., Autio, H., Stavén, S., Koivisto, H., Kojima, M., Antila, H., Miettinen, P.O., Kärkkäinen, E., Karpova, N., Vesa, L., Lindemann, L., Hoener, M.C., Tanila, H., Castrén, E., The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease. PLoS One, 8, 2013, e68722.
60. Riemenschneider, M., Schwarz, S., Wagenpfeil, S., Diehl, J., Müller, U., Förstl, H., Kurz, A., A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol. Psychiatry 7 (2002), 782–785.
61. Rosa, E., Fahnestock, M., CREB expression mediates amyloid β-induced basal BDNF downregulation. Neurobiol. Aging 36 (2015), 2406–2413.
62. Rosch, H., Schweigreiter, R., Bonhoeffer, T., Barde, Y.A., Korte, M., The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 7362–7367.
63. Saarelainen, T., Lukkarinen, J.A., Koponen, S., Gröhn, O.H., Jolkkonen, J., Koponen, E., Haapasalo, A., Alhonen, L., Wong, G., Koistinaho, J., Kauppinen, R.A., Castrén, E., Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia. Mol. Cell. Neurosci 16 (2000), 87–95.
64. Savaskan, E., Müller-Spahn, F., Olivieri, G., Bruttel, S., Otten, U., Rosenberg, C., Hulette, C., Hock, C., Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur. Neurol. 44 (2000), 172–180.
65. Shin, M.K., Kim, H.G., Baek, S.H., Jung, W.R., Park, D.I., Park, J.S., Jo, D.G., Kim, K.L., Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Neurobiol. Aging 35 (2014), 990–1001.
66. Szapacs, M.E., Numis, A.L., Andrews, A.M., Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiol. Dis. 16 (2004), 572–580.
67. Tong, L., Balazs, R., Thornton, P.L., Cotman, C.W., Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J. Neurosci. 24 (2004), 6799–6809.
68. Vepsäläinen, S., Castren, E., Helisalmi, S., Iivonen, S., Mannermaa, A., Lehtovirta, M., Hänninen, T., Soininen, H., Hiltunen, M., Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J. Neurol. 252 (2005), 423–428.
69. Vitolo, O.V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., Shelanski, M., Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 13217–13221.
70. Voineskos, A.N., Lerch, J.P., Felsky, D., Shaikh, S., Rajji, T.K., Miranda, D., Lobaugh, N.J., Mulsant, B.H., Pollock, B.G., Kennedy, J.L., The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch. Gen. Psychiatry 68 (2011), 198–206.
71. Weinstein, G., Beiser, A.S., Choi, S.H., Preis, S.R., Chen, T.C., Vorgas, D., Au, R., Pikula, A., Wolf, P.A., DeStefano, A.L., Vasan, R.S., Seshadri, S., Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham heart study. JAMA Neurol. 71 (2014), 55–61.
72. Wong, J., Higgins, M., Halliday, G., Garner, B., Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease. Neuroscience 210 (2012), 363–374.
73. Yasutake, C., Kuroda, K., Yanagawa, T., Okamura, T., Yoneda, H., Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006), 402–406.
74. Zeng, Y., Zhao, D., Xie, C.W., Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity. J. Alzheimers Dis. 21 (2010), 823–831.
75. Zhang, Y., Pardridge, W.M., Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Res. 889 (2001), 49–56.
76. Zhang, Y., Pardridge, W.M., Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 1111 (2006), 227–229.
77. Zheng, Z., Sabirzhanov, B., Keifer, J., Oligomeric amyloid-{beta} inhibits the proteolytic conversion of brain-derived neurotrophic factor (BDNF), AMPA receptor trafficking, and classical conditioning. J. Biol. Chem. 285 (2010), 34708–34717.